Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

16.21 +0.23 (+1.47%)
Streaming Delayed Price Updated: 11:24 AM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 251,131
Open 16.10
Bid (Size) 16.21 (7)
Ask (Size) 16.22 (3)
Prev. Close 15.98
Today's Range 15.92 - 16.35
52wk Range 9.215 - 21.00
Shares Outstanding 41,397,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
From Pomerantz LLP
Via GlobeNewswire
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire

Performance

YTD
-1.1%
-1.1%
1 Month
+16.7%
+16.7%
3 Month
+55.8%
+55.8%
6 Month
-5.6%
-5.6%
1 Year
+24.5%
+24.5%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Axogen Stock Down 11% In Pre-Market Today?
Via Stocktwits
Earnings Scheduled For August 5, 2025
Via Benzinga
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
Via Benzinga
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months
Via Benzinga
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted
Via Investor's Business Daily
Which stocks are moving before the opening bell on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
From Axogen, Inc.
Via GlobeNewswire
Axogen (AXGN) Q2 Revenue Jumps 18%
Via The Motley Fool
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance
Via Chartmill
Topics Earnings
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Axogen, Inc. Reports Second Quarter 2025 Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
From Axogen, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
What Analysts Are Saying About Axogen Stock
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Axogen, Inc. Reports 2025 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Chief Financial Officer Transition
From Axogen, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Axogen, Inc. - Common Stock publicly traded?
Yes, Axogen, Inc. - Common Stock is publicly traded.
What exchange does Axogen, Inc. - Common Stock trade on?
Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axogen, Inc. - Common Stock?
The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
What is the current price of Axogen, Inc. - Common Stock?
The current price of Axogen, Inc. - Common Stock is 16.21
When was Axogen, Inc. - Common Stock last traded?
The last trade of Axogen, Inc. - Common Stock was at 09/08/25 11:24 AM ET
What is the market capitalization of Axogen, Inc. - Common Stock?
The market capitalization of Axogen, Inc. - Common Stock is 671.25M
How many shares of Axogen, Inc. - Common Stock are outstanding?
Axogen, Inc. - Common Stock has 671M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.